Marijuana and lung diseases

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 2, 2014, Pages 173-179

  Joshi, Manish ^a,b   Joshi, Anita ^c   Bartter, Thaddeus ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c NONE

Author keywords

chronic obstructive pulmonary diseases; lung cancer; marijuana smoking

Indexed keywords

AIRWAY RESISTANCE; CANNABIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MARIJUANA SMOKING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 84894088606     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000026     Document Type: Review

References (53)

1. American Cancer Society. Marijuana. http://www.cancer.org/treatment/ treatmentsandsideeffects/complementaryandalternativemedicine/ herbsvitaminsandminerals/marijuana. [Accessed 18 September 2013]
2. Aggarwal SK, Carter GT, Sullivan MD, et al. Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. J Opioid Manag 2009;5:153-168.
3. Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr 2006;28:153-157.
4. United Nations Office on Drugs and Crime. World Drug Report 2013. United Nations publication, Sales No. E.13. XI.6. www.unodc.org unodc/secured/wdr/ wdr2013/World-Drug-Report-2013.pdf. [Accessed 17 September 2013]
5. Van Sickle MD, Duncan M, Kingsley PJ, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005;310:329-332.
6. National Institute on Drug Abuse, US National Institutes of Health. Research Report Series. Marijuana abuse. http://www.drugabuse.gov/sites/default/ files/rrmarijuana.pdf. [Accessed 30 September 2013]
7. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003;42:327-360.
8. Lee ML, Novotny M, Bartle KD. Gas chromatography/mass spectrometric and nuclear magnetic resonance spectrometric studies of carcinogenic polynuclear aromatic hydrocarbons in tobacco and marijuana smoke condensates. Anal Chem 1976;48:405-416.
9. Moir D, Rickert WS, Levasseur G, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008;21:494-502.
10. Lee MH, Hancox RJ. Effects of smoking cannabis on lung function. Expert Rev Respir Med 2011;5:537-546.
11. Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral D9-tetrahydrocannabinol in healthy young men. N Engl J Med 1973;289:336-341.
12. Vachon L, Fitzgerald. Solliday NH, et al. Single-dose effect of marijuana smoke: bronchial dynamics and respiratory center sensitivity in normal subjects. N Engl J Med 1973;288:985-989.
13. Tashkin DP, Shapiro BJ, Frank IM. Acute effects of smoked marijuana and oral D9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis 1974;109:420-428.
14. Tashkin DP, Shapiro BJ, Frank IM. Acute effects of marijuana on airway dynamics in spontaneous and experimentally induced bronchial asthma. In: Braude M, Szara S, editors. Pharmacology of marijuana. New York: Raven Press; 1976. pp. 785-801.
15. Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007;167:221-228.
16. Henderson RL, Tennant FS, Guerry R. Respiratory manifestations of hashish smoking. Arch Otolaryngol 1972;95:248-251.
17. Aldington S, Williams M, Nowitz M, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007;62:1058-1063.
18. Tan WC, Lo C, Jong A, Xing L, et al. Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group. Marijuana and chronic obstructive lung disease-a population-based study. CMAJ 2009;180:814-820.
19. Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J 2010;35:42-47.
20. Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. J Am Med Assoc 2012;307:173-181. This is the most recently published longitudinal cohort study and suggests a possibility of airflow obstruction with heavy marijuana use, but no changes in occasional marijuana smokers. This observation may have important consequences for marijuana users, both for medicinal and recreational purposes.
21. Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a US sample. J Gen Intern Med 2004;20:33-37.
22. Fligiel SEG, Roth MD, Kleerup EC, et al. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 1997;112:319-326.
23. Roth MD, Arora A, Barsky SH, et al. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 1998;157:928-937.
24. Tashkin DP, Simmons M, Tseng C-H. Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD 2012;9:367-374. This is a unique study that demonstrates the benefit of marijuana smoking cessation with respect to the resolution of chronic bronchitis. It highlights the importance of marijuana smoking cessation for symptom relief.
25. Hoffmann D, Brunneman DK, Gori GB, Wynder EL. On the carcinogenicity of marijuana smoke. Recent Adv Phytochem 1975;9:63-81.
26. Barsky SH, Roth MD, Kleerup EC, et al. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine and/or tobacco. J Natl Cancer Inst 1998;90:1198-1205.
27. Tashkin DP, Baldwin GC, Sarafian T, et al. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol 2002;42:71S-81S.
28. Maertens RM, White PA, Williams A, Yauk CL. A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro. Toxicology 2013;308:60-73. This study compared tobacco and marijuana smoke condensates using toxicogenomic approach and demonstrated that the pathways affected by MSC are similar to those with TSC. This observation has strengthened the link supporting the biological plausibility of marijuana smoking as a risk factor for the development of lung cancer.
29. Hashibe M, Morgenstern H, Cui Y, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006;15:1829-1834.
30. Hashibe M, Straif K, Tashkin DP. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005;35:265-275.
31. Mehra R, Moore BA, Crothers K, et al. The association between marijuana smoking and lung cancer. Arch Intern Med 2006;166:1359-1367.
32. Berthiller J, Straif K, Boniol M, et al. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 2008;3:1398-1403.
33. Callaghan RC, Allebeck P, Sdorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control 2013;24:1811-1820. This is a large study with most extended follow-up suggesting two-fold risk of lung cancer in heavy marijuana users. The observations warrant caution against heavy marijuana use.
34. Beshay M, Kaiser H, Niedhart D, et al. Emphysema and secondary pneumothorax in young adults smoking marijuana. Eur J Cardiothorac Surg 2007;32:834-838.
35. Wu TC, Tashkin DP, Djahed B, et al. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988;318:347-351.
36. Fligiel SE, Beals TF, Tashkin DP, et al. Marijuana exposure and pulmonary alterations in primates. Pharmacol Biochem Behav 1991;40:637-642.
37. Scheel AH, Krause D, Haars H, et al. Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report. Diagn Pathol 2012;7:26. The study report highlights the potential harmful effects of adulterated marijuana joints.
38. Bowles DW, O'Bryant CL, Camidge DR, Jimeno A. The intersection between cannabis and cancer in the United States. Crit Rev Oncol Hematol 2012;83:1-10. A good review focusing on the potential role of cannabis in development of cancer and also its role in care of cancer patients.
39. Vinciguerra V, Moore T, Brennan E. Inhalation marijuana as an antiemetic for cancer chemotherapy. N Y State J Med 1988;88:525-527.
40. Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013;33:195-209. A good review demonstrating cannabis pharmacological properties.
41. Munson AE, Harris LS, Friedman MA, et al. Antineoplastic activity of cannabinoids. J Natl Cancer Inst 1975;55:597-602.
42. Blá zquez C, González-Feria L, Lvarez L, et al. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res 2004;64:5617-5623.
43. Yamada T, Ueda T, Shibata Y, et al. TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer. Urology 2010;76:509 e1-e7.
44. Vara D, Salazar M, Olea-Herrero N, et al. Antitumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 2011;18:1099-1111.
45. Massi P, Solinas M, Cinquina V, Parolaro D. Cannabidiol as potential anti-cancer drug. Br J Clin Pharmacol 2013;75:303-312. An experimental tissue culture study demonstrating antitumorogenic effect of cannabinoids.
46. Guzman M, Duarte MJ, Blazquez C. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 2006;95:197-203.
47. Crean RD, Crane NA, Mason BJ. An evidencebasedreviewof acute and longterm effects of cannabis use on executive cognitive functions. J Addict Med 2011;5:1-8.
48. Hall W, Degenhardt L. Adverse health effects of nonmedical cannabis use. Lancet 2009;374:1383-1391.
49. Blows S, Ivers RQ, Connor J, et al. Marijuana use and car crash injury. Addiction 2005;100:605-611.
50. Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem 2013;59:478-492. A good review that highlights substantial driving impairment in marijuana smokers.
51. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. Br Med J 2012;344:e536. This is the first systematic review of high-quality studies which concluded that acute cannabis consumption nearly doubles the risk of a collision resulting in serious injury or death.
52. Gonzalez R, Swansonb JM. Long-term effects of adolescent-onset and persistent use of cannabis. Proc Natl Acad Sci USA 2012;109:15970-15971. An editorial summarizing the emerging evidence of neurocognitive decline in persistent cannabis users.
53. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 2012;109:E2657-E2664. A recently published study in which individuals were followed from birth to age 38 years. The study results highlight that persistent cannabis use is associated with neuropsychological decline.